BIRAC LEAP Fund: A Complete Guide

Some biotech startups clear their first valley of death, proof of concept validated, early capital secured, a functioning product taking shape, only to find a second, sometimes steeper gap waiting just ahead. Scaling a biotech company from it works in the lab to it works reliably at commercial scale demands a different order of capital altogether, and it is a stage where many otherwise promising ventures quietly stall, unable to bridge from early traction to genuine growth funding.

The LEAP Fund is the Biotechnology Industry Research Assistance Council's answer to that second, later stage gap. Where the SEED Fund helps startups cross their first valley of death, LEAP is built for the ventures that have already done that, companies with real early traction that now need a larger capital infusion to scale meaningfully, close the distance to institutional investment, and move confidently toward sustainable growth. Like SEED Fund, LEAP works through BIRAC's trusted network of BioNEST incubators, ensuring later stage capital still arrives paired with continuity, mentorship, and institutional credibility.

The Funding Opportunity: What the BIRAC LEAP Fund Actually Offers

• Fund allocation to incubators: each selected incubator, acting as a LEAP Fund partner, receives grant in aid support of Rs. 500 lakh per cycle for deployment into biotech startups within their network, a substantially larger allocation than the earlier stage SEED Fund.
• Funding support of up to Rs. 1 crore per startup, reflecting the larger capital needs of later stage, growth focused biotech companies compared to SEED Fund's earlier stage ticket size.
• Investment structure: capital is deployed into startups as equity or equity linked instruments, continuing the same investment logic as SEED Fund but at a larger scale suited to later stage companies.
• Purpose: LEAP is explicitly positioned to help biotech startups scale beyond early traction, strengthening their position to attract institutional venture capital and larger growth stage investment.

Who is eligible

• Must be a biotech or life sciences startup with demonstrated early traction, typically having already progressed beyond the proof of concept stage that SEED Fund is designed to support.
• Startups previously supported through SEED Fund or with a comparable track record of validated technology and market movement are natural candidates.
• Must generally meet BIRAC's standard startup criteria: registered under the Companies Act, 2013, with at least 51 percent shareholding held by Indian citizens, excluding OCI and PIO holders.
• Should be working with, or seeking association with, an incubator that qualifies as a LEAP Fund partner.

Incubator eligibility, for the institutions applying to become LEAP Fund partners

• Must already be an established BIRAC SEED Fund partner. LEAP builds directly on institutions that have already proven themselves managing earlier stage capital.
• Must have been operational for at least 5 years, a notably higher bar than the 3 year requirement for SEED Fund partners, reflecting the greater scale and responsibility of managing later stage capital.

How the process works

1. Identify a BIRAC LEAP Fund partner incubator. These are, by design, more experienced institutions that have already run SEED Fund successfully.
2. Apply through that incubator's own evaluation process, presenting evidence of your startup's early traction and growth trajectory.
3. If selected, receive later stage equity or equity linked funding, deployed from the incubator's allocated LEAP corpus, along with continued mentorship geared toward institutional investment readiness.

Because LEAP Fund partner incubators are fewer in number than SEED Fund partners, given the higher eligibility bar, it is worth confirming directly with BIRAC or a target incubator whether an active LEAP cycle is currently open.

The Incubators Powering the BIRAC LEAP Fund

LEAP Fund partners represent some of the most established institutions in BIRAC's incubator network, organizations that have already successfully managed SEED Fund deployment and built a five year track record supporting early stage biotech ventures. This deliberate escalation, from SEED Fund's 3 year incubator requirement to LEAP's 5 year bar, ensures that later stage capital, which carries more risk and requires more sophisticated evaluation, is managed by institutions with genuinely proven experience. A few institutions running the LEAP Fund include: